Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Novel tachykinin NK1 antagonists prepared and tested by Takeda

April 7, 2006

MediciNova begins phase I study for urinary incontinence treatment MN-246

April 4, 2006

Phase III hepatorenal syndrome study of terlipressin completes enrollment

March 27, 2006

Enrollment completed in second phase III study of Sanctura XR

March 24, 2006

Enrollment completed in phase II study of TH-070 for BPH

March 23, 2006

Novel urological agents disclosed in recent patent literature

March 21, 2006

ALK5 inhibitor a novel therapeutic approach for the treatment of fibrosis

March 20, 2006

TGF-beta1 gene-silencing treatment for progressive renal diseases

March 17, 2006

Intravenous and oral conivaptan raises serum sodium in heart failure patients

March 17, 2006

Enrollment completed in first of two phase III studies for Sanctura XR

March 9, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...